Young Dogs With Splenic Cancer Live Far Longer on Chemotherapy, Landmark Trial Reveals
A phase I trial of propranolol plus doxorubicin found no survival benefit from the beta-blocker, but revealed that young adult ...
A phase I trial of propranolol plus doxorubicin found no survival benefit from the beta-blocker, but revealed that young adult ...
New laboratory research shows that canine hemangiosarcoma cell lines resist the chemotherapy drug temozolomide through a mechanism independent of the ...
Researchers at the University of São Paulo used a qPCR-based gene expression panel to divide canine splenic hemangiosarcoma into three ...
A full-thickness biopsy study of 40 dogs reveals that PD-L1 expression, rather than conventional histological features, is the strongest predictor ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine